Skip to main content
Thomas Rosenfeld, MD, Dermatology, Worcester, MA

ThomasLeeRosenfeldMD

Dermatology • Worcester, MA

Dermatologic Surgery

Chief of Dermatology, Reliant Medical Group

Join to view full profile

Dr. Rosenfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rosenfeld's full profile

Already have an account?

  • Office

    5 Neponset St
    Reliant Medical Group
    Worcester, MA 01606
    Phone+1 508-595-2655

Education & Training

  • Roger Williams Medical Center
    Roger Williams Medical CenterResidency, Dermatology, 1980 - 1983
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1978 - 1980
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 1978

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1983 - 2025
  • RI State Medical License
    RI State Medical License 1980 - 1991
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Member Mensa, 2020-2022
  • Regional Top Doctor Castle Connolly, 2014
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Join now to see all

Publications & Presentations

Journal Articles

  • Evaluation of Melanoma/Skin Cancer Screening in Massachusetts  
    Koh, H.C., Rosenfeld, T. et. al., Cancer, 6/29/2006
  • Scabies presenting as bullous pemphigoid-like eruption  
    Bhawan, J., Rosenfeld, T. et.al., J Am Acad Derm, 2/1991

Committees

  • Member, Executive Committee, WDMS 2008 - Present
  • Chairman, Committee on Nominations, Mass Med Society 2015 - 2016

Research History

  • Clinical InvestigatorBerlex Labs. PI 30, Phase 3, Doulble Blind study of Finevin Gel2001 - 2001
  • Clinical investigatorGalderma ORCA Phase 3 Clinical Trial. Protocol GLI.04.SPR.US10120
  • Clinical InvestigatorGalderma COBRA Phase 3 Clinical Trial, Protocol GLI.04.SPR.US10029
  • Clinical InvestigatorGalderma MORE Phase 3 Clinical Trial, Protocol GAL.04.SPR.U10000
  • Clinical InvestigatorGalderma PIGMENT Plase 3 Clinical Trial, Protocol GLI.04.SPR.001

Professional Memberships

Other Languages

  • Spanish

Dr. Thomas Rosenfeld, Dr. Thomas Rosenfeld, MD, Dr. T Rosenfeld, Dr. Thomas Lee Rosenfeld